NASDAQ
Enanta Pharmaceuticals, Inc. (ENTA) has a eps (basic) of $-3.84 as of Tuesday, September 30, 2025. Basic EPS divides net income by the weighted average number of common shares outstanding, measuring profit allocated to each share.
No price data available for this timeframe.